CCM Biosciences is a biotech firm committed to uncovering and advancing innovative medications, such as compounds, genetic treatments, biological products, and nanomedicines. CCM's proprietary drug discovery platforms were created at Chakrabarti Advanced Technology, a privately financed R&D institute established in 2010 with researchers in the US, France, and India and with articles in prominent scientific publications such as PNAS, Nucleic Acids Research, American Chemical Society publications, and Nature Publishing Group journals.